The Center for Integration of Science and Industry is proud to present the Innovator’s Business Series
The Innovator's Business Series features talks and informal discussions with thought leaders from academia and industry focused on best practices in translational science. Speakers present the perspective of successful innovators in translating scientific advances into public value. The theme of the series centers on the need for integrating technological and business innovation in the fields of biotechnology, healthcare, high-tech and alternative energy.
Fred Ledley discusses Bentley’s biotechnology mini-MBA and what it offers you and your company. WATCH VIDEO
Next dates TBD
Wednesday, February 20, 2019 @ 5:00 PM | Wilder Pavilion, Bentley University
Businesses have the power to democratize innovation. However, the incentives of the business model are key to its outcomes. This fireside chat with Dr. Gary Nabel centered on frugal innovation and how economic incentives can align with good public health outcomes to de-risk the business of saving lives.
Dr. Gary J. Nabel, M.D., Ph.D., is Chief Scientific Officer, Global Research and Development, and Head of the North American R&D Hub at Sanofi. In addition to serving as Senior Vice President for the company, Dr. Nabel also oversees the Breakthrough Lab, which developed the first trispecific antibodies now in development for HIV as published in Science, as well as, cancer immunotherapies and novel vaccines. The Chief Scientific Office sponsors the iAwards, the Postdoctoral and Innovation Fellows Programs, and the Global Science Awards.
Institute Professor, Massachusetts Institute of Technology
Koch Institute for Integrative Cancer Research
Former Vice President for the U.S. Rare Disease Group at Biogen
Senior Medical Director of Clinical Development at Biogen
Professor, Practice of International Development
Director, Science, Technology, and Globalization Project
Faculty Chair of the Mason Fellows Program
Belfer Center for Science and International Affairs
Harvard Kennedy School
Distinguished Professor of Political Science, Northeastern University
Governor of Massachusetts (1975-1979, 1983-1991)
1988 Democratic Nominee for President of the United States
Former General Council, BASF Bioresearch
Former President, BASF Bioresearch
President & CEO, MassBio
President and Chief Executive Officer of Boston Children's Hospital
President Emeritus and Senior Fellow of the Institute for Healthcare Improvement
Formerly the Administrator of the Centers for Medicare & Medicaid Services
Executive Chairman, Alkeus Pharmaceuticals, Inc.
Formerly the President, CEO and Chairman of Vertex Pharmaceuticals
Executive Vice-President for Technology and Innovation, IBM (retired)
President and CEO of Envivo Pharmaceuticals
Formerly the President and CEO of Massachusetts Life Sciences Center